Brandon S. Smith is a seasoned executive who currently serves as the Chief Operating Officer at Prothena PLC, a clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative and rare peripheral amyloid diseases. With over two decades of experience in the biopharmaceutical industry, Smith has a proven track record of leading operations and driving growth in both large and small organizations. Prior to joining Prothena, he held senior leadership positions at several prominent companies, including Genentech and Biogen, where he was instrumental in overseeing the successful development and commercialization of groundbreaking therapies. At Prothena, Smith plays a pivotal role in steering the company's strategic direction and operational execution. As COO, he is responsible for overseeing the company's day-to-day operations, including manufacturing, supply chain management, and quality assurance. Under his leadership, Prothena has made significant strides in advancing its pipeline of innovative treatments, with several promising candidates currently in clinical trials. Smith's expertise in operational excellence and his ability to foster a culture of collaboration and innovation have been key factors in Prothena's continued success and growth. In addition to his professional achievements, Smith is an active member of the biotechnology community and frequently shares his insights on industry trends and best practices. He holds a Bachelor of Science degree in Chemical Engineering from the Massachusetts Institute of Technology and an MBA from Harvard Business School. Throughout his career, Smith has demonstrated a commitment to advancing the field of biopharmaceuticals and improving the lives of patients worldwide.